News roundup Monday, September 23

The latest from BioStock

» Mentice strengthens cardiology education in Germany through partnership
» WntResearch is in turmoil after disappointing results
» Saniona comments on approval to initiate epilepsy study
» The most shorted life science stocks in the Nordics
» Abliva leads the fight against mitochondrial diseases 

Read the newsletter for v.38 here.

See all presentations and panels from BioStock Investing in Life Science – below.

The latest news

Biovica receives significant orders for TKa testing services. Read more.

Alzinova appoints Tord Labuda to a new CEO. Read more.

BrainCool cancels the loan agreement with the EIB. Read more.

SynAct initiates the phase IIb ADVANCE study with resomelagon in the United States. Read more.

Hospitals in Greenland choose Sects radiology solution. Read more.

S2Medicals Rights issue subscribed to 97 percent. Read more.

Active Biotech announces a new share issue of SEK 35 million. Read more.

Two leading US microbiology laboratories present interim data with Q-lineas ASTar system. Read more.

ADDvise receives orders worth USD 1,3 million. Read more.

ChemoMetec bids on Ovizio Imaging Systems. Read more.

AstraZeneca FluMist approved for self-administration in the United States. Read moreThe company's pharmaceuticals Phasenra Marketing approval in the EU is recommended for the treatment of eosinophilic granulomatosis with polyangiitis. Read moreDatopotamab deruxtecan did not demonstrate any clinical benefit compared to chemotherapy in breast cancer patients with metastatic HR-positive, HER2-low or -negative disease. Read more.

Magnasense calls for payment of part of Tranche 3 of SEK 2,50 million from Atlas Special Opportunities. Read more.

Board member of Redsense Medical departs. Read more.

Intervacc assesses the short-term remaining situation regarding Stringvac. Read more.

Prostatype Genomics publishes newsletters. Read more.

Nightingale Health changes the CEO's incentive program. Read more.

Perpetua Medical announces timetable for share reverse split. Read more.

Last day of trading in XP Chemistries TO2 is today. Read more.